Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model.
Q Q QuarteyRobert J MillerB L PinskerU J OkohWilliam D ShipmanElisabeth A GeorgeChibuikem NwizuL A BarnesMichelle L KernsJulie A CaffreyOluseyi AliuIsabelle D BrownF SuccariaJanielle P MaynardAmber S HerbertSewon KangLloyd S MillerGinette A OkoyeAngel S ByrdPublished in: Clinical and experimental dermatology (2019)
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease originating from the pilosebaceous unit, in which patients develop painful abscesses, sinus tracts, nodules and scarring, typically in intertriginous areas. Major gaps in our understanding of HS exist, and these may be partially due to the lack of an animal model for experimental studies. We developed an HS xenograft mouse model using human HS lesions grafted onto immunocompromised mice. Although the model had its limitations, several informative lessons were learned, which may contribute to future attempts at an HS animal model.
Keyphrases
- hidradenitis suppurativa
- mouse model
- end stage renal disease
- endothelial cells
- ejection fraction
- chronic kidney disease
- newly diagnosed
- oxidative stress
- prognostic factors
- type diabetes
- metabolic syndrome
- current status
- patient reported outcomes
- insulin resistance
- skeletal muscle
- adipose tissue
- induced pluripotent stem cells
- high fat diet induced
- wild type
- drug induced
- pluripotent stem cells